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ABSTRACT 
 
During dorsal closure the lateral epithelia on each side of the embryo migrate dorsally over 
the amnioserosa and fuse at the dorsal midline. Detailed genetic studies have revealed that 
many molecules are involved in this epithelial sheet movement, either with a signaling 
function or as structural or motor components of the process. Here we report the 
characterization of cabut (cbt), a new Drosophila gene involved in dorsal closure. cbt is 
expressed in the yolk sac nuclei and in the lateral epidermis. The Cbt protein contains three 
C2H2-type zinc fingers and a serine-rich domain, suggesting that it functions as a transcription 
factor. cbt mutants die as embryos with dorsal closure defects. Such embryos show defects in 
the elongation of the dorsal-most epidermal cells as well as in the actomyosin cable assembly 
at the leading edge. A combination of molecular and genetic analyses demonstrates that cbt 
expression is dependent on the JNK cascade during dorsal closure, and it functions 
downstream of Jun regulating dpp  expression in the leading edge cells. 
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INTRODUCTION 
 
During Drosophila embryogenesis, dorsal closure, germband retraction, and head involution 
compose the major morphogenetic movements that participate in organogenesis of the first 
instar larva. Dorsal closure (DC) is the last of these movements that occurs following 
germband retraction. At the onset of closure, the epidermis of the Drosophila embryo has a 
hole on its dorsal side that is occupied by the amnioserosa, an epithelium of large flat cells 
that do not contribute to the larva. During DC, the lateral epithelia on each side of the embryo 
migrate dorsally over the amnioserosa and fuse at the dorsal midline. This process involves 
dramatic and coordinated morphological changes of both the epidermal and amnioserosal 
cells (Jacinto et al., 2002). Recent studies have demonstrated that an extraembryonic tissue, 
the yolk sac, also contributes to DC (Narasimha and Brown, 2004;Reed et al., 2004). 
The movement of the epidermal sheets is directed by the dorsal most row of epidermal 
cells, which are in contact with the amnioserosa (Noselli and Agnes, 1999). At the beginning 
of DC, these dorsal-most epithelial (DME) cells elongate along the dorsoventral (D-V) axis of 
the embryo. This seems to be achieved by the accumulation of large quantities of filamentous 
actin (F-actin) and non muscle myosin at their interface with the amnioserosa, which is 
known as the leading edge (Young et al., 1993). First, the accumulation of actin occurs 
between cells at the level of adherens junctions, but later on, a cable of actin and myosin 
assembles across the leading edge (LE), and F-actin is incorporated into dynamic protrusions 
(Kaltschmidt et al., 2002). It seems that actin dynamics at the LE is preceded by the planar 
polarization of the DME cells associated with a reorganization of the cytoskeleton. This is 
reflected by the redistribution of several cell-surface-associated proteins in the plane of the 
epithelium that occurs towards the end of DC. For example, the distribution of the septate-
junction-associated proteins Disc large (Dlg) and Fasciclin III (FasIII) changes as DC occurs. 
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At the beginning of DC they are distributed symmetrically around the epidermal cells, but as 
closure progresses they clear from the apical membrane facing the LE. The planar 
polarization of these cells is essential for DC since in its absence the process occurs 
abnormally (Kaltschmidt et al., 2002). 
During DC cell shape changes in the amnioserosa begin with apical constriction of cells at 
the anterior and posterior ends of the tissue. The middle cells in between the two clusters also 
change shape since they are first elongated perpendicular to the A-P axis of the embryo, but at 
the end of DC they are both elongated along the A-P axis and apically constricted (Harden et 
al., 2002). This cell shape change is accompanied by an invagination of the tissue. Laser 
ablation experiments show that the amnioserosa is not passively squeezed by the advancing 
epithelial sheets, but exerts some tension that helps to draw them together (Kiehart et al., 
2000). Recently, it has been shown that the basal surface of the amnioserosa is in close 
apposition with the yolk sac membrane. This intimate contact between these two 
extraembryonic tissues is mediated by integrins and prevents premature anoikis of the 
amnioserosa, suggesting that the yolk cell contributes to dorsal closure since it is essential for 
amnioserosa survival (Narasimha and Brown, 2004; Reed et al., 2004). 
Genetic analyses have identified numerous genes required for DC. DC mutants die during 
embryogenesis and present various shapes and sizes of holes in cuticle preparations of the 
resulting larvae (Jacinto and Martin, 2001). Molecular analyses of these genes have revealed 
that some of them encode gene products that are structural and motor components of the 
process. That is the case of zipper (zip) or canoe (cno), which code for the motor protein non-
muscle myosin II and an adherens-junction-associated protein, respectively (Miyamoto et al., 
1995; Young et al., 1993). Besides, several signaling pathways like the Jun N-terminal kinase 
(JNK) cascade and Wg signaling are also important in regulating the initiation and 
maintenance of epithelial movements associated with DC (reviewed by Harden, 2002). Prior 
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to DC the JNK signaling cascade is active in both the amnioserosa and the LE of the 
epidermis (Reed et al., 2001). Later on, it is downregulated in the amnioserosa but not in the 
LE cells, activating the localized transcription of two target genes: dpp  and a dual specifity 
phosphatase, puckered  (puc) (Glise and Noselli, 1997; Martín-Blanco et al., 1998; Riesgo-
Escovar and Hafen, 1997; Zeitlinger et al., 1997). It has been recently proposed that a 
subsequent activation of JNK signaling in the amnioserosa could trigger the disintegration and 
death of this tissue after closure of the epidermis (Reed et al., 2004). Besides, several studies 
of DC in embryos with impaired JNK and Wg signaling have also shown that both are 
essential for actin dynamics and cytoskeletal organization of the DME cells, but only Wg 
signaling seems to be required for the polarization of epidermal cells in the initial phases of 
DC (Kaltschmidt et al., 2002; McEwen et al., 2000; Morel and Martinez-Arias, 2004; Ricos et 
al., 1999). 
In this paper, we report the identification and genetic analysis of cabut (cbt), a novel gene 
implicated in Drosophila embryogenesis. It is expressed in the yolk cell and in the lateral 
epidermis, and encodes a putative transcription factor containing C2H2 zinc finger motifs. 
Phenotypic analyses of cbt mutant embryos show that loss of Cbt function affects several key 
events in DC: cell shape change in the epidermis, cytoskeleton activity, JNK signaling, and 
occasionally polarity of the DME cells. Taken together, our results indicate that cbt has a role 
in DC, downstream of the JNK cascade, regulating dpp expression at the LE.  
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MATERIALS AND METHODS 
 
Fly strains 
The EP line EP(2)2237 (Rørth et al., 1998) was used for the characterization of the cbt locus. 
We mobilized the EP element in that line using the Sp/CyO; Sb, ∆2-3/TM6, Ubx stock as 
external source of transposase and several imprecise lethal excisions were recovered. The 
Tp(2;1)odd1.10 transposition line (Nusslein-Volhard et al., 1985) was used to confirm the 
genomic location of the excision alleles. 
The UAS-cbt wild type construct was obtained by cloning the SD06353 cDNA into the 
pUAST Drosophila transformation vector (Brand and Perrimon, 1993). P-element-mediated 
Drosophila germ-line transformation of this construct was performed as described (Spradling 
and Rubin, 1982). 
The following GAL4 and UAS lines were also used: 69B-GAL4, da-GAL4 (both from 
Bloomington), en-GAL4 (Tabata et al., 1995), arm-GAL4 (Sanson et al., 1996), P0180-
GAL4 (Narashima et al., 2004), UAS-HepACT (Weber et al., 2000), UAS-dpp (a gift from S. 
Casas). The mutant alleles used in this work are: bsk2 (Sluss et al., 1996), jun2 (Nusslein-
Volhard et al., 1984), mys1 (Digan et al., 1986), pucE69 (Ring and Martinez-Arias, 1993) and 
bsgB39.1M2 (Reed et al., 2004). 
To distinguish the cbtEP(2)2237E1 and cbtEP(2)2237E28 homozygous mutant embryos from their 
heterozygous siblings, we made use of balancer chromosomes carrying a lacZ (CyO,wg-lacZ; 
Ingham et al., 1991) or a GFP (CyO,ubi-GFP; Bloomington) transgene. 
 
Molecular analyses 
The exact point of the EP element insertion in the EP(2)2237 line was determined by inverse 
PCR as described in the BDGP web site. PCR products were cloned in TOPO 2.1 (Invitrogen) 
and sequenced. Searches in Drosophila databases using those sequences identified several 
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ESTs within the immediate vicinity of the EP insertion. Two of them were selected for 
sequence analysis: LD06353 and SD05727. We fully sequenced LD06353 (GenBank 
accession no. AJ749862), which corresponds to the cbt-RA isoform. Partial sequencing of 
SD05727 revealed that it is identical in sequence to SD05726 (data not shown) and 
corresponds to the cbt-RB isoform. To determine the exon-intron structure of cbt, we 
compared the genomic and the ESTs sequences from BDGP, and also the cDNA sequences 
determined by us. We found 23 ESTs derived from the cbt gene: 20 correspond to the cbt-RA 
isoform, two correspond to the cbt-RB isoform, and one is a partial sequence that could 
correspond to either of them. 
To determine the molecular lesion present in the mutants, we performed single-embryo 
DNA amplifications of non-GFP embryos collected from cbtEP(2)2237E1/CyO,ubi-GFP and 
cbtEP(2)2237E28/CyO, ubi-GFP stocks using different pairs of primers to amplify overlapping 
fragments encompassing the whole cbt coding region. These PCR products were purified and 
cloned in TOPO 2.1 for sequencing. In the cbtEP(2)2237E28 allele, we found 30 additional bp at 
the EP-element insertion point (19 bp correspond to the EP-element, and 11 bp are a genomic 
duplication). The coding region of cbtEP(2)2237E1 allele was wild type. A set of primers were 
designed to amplify the genomic region 0.5 kb downstream (including the 3´UTR from 
Arc105) and 4.9 kb upstream of the cbt locus (see Supplementary material). Primers between 
3.9 kb and 4.9 kb upstream of cbt (5´-AGACGACCTTCAGTCGGG-3  ´and 5´-
GCTGTTCACGTTGACTTC-3 )´ failed to amplify the expected product in cbtEP(2)2237E1  
homozygous embryos as they did in wild-type, in EP(2)2237 and in cbtEP(2)2237E28 
homozygous embryos. 
 
In situ hybridization 
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In situ hybridizations to whole-mount embryos were performed as described (Tautz and 
Pfeifle, 1989). In situ hybridizations to imaginal discs were done following the protocol 
described by Cheung et al. (1992) with several modifications. Antisense RNA probes were 
generated with the DIG RNA labeling kit SP6/T7 (Roche). The wild-type cbt expression 
pattern was determined in OrR embryos using the SD06353 cDNA as template for riboprobe 
synthesis. A complete dpp cDNA (Lockwood and Bodmer, 2002) was used to generate dpp 
antisense riboprobes. Sense probes generated in parallel with the same templates were used 
as negative controls in all cases. 
 
RT-PCR and Northern blot 
Total RNA was isolated from 0-22h embryos using Tri-Reagent (Sigma) following the 
supplier´s instructions. RT-PCRs were performed with RNA from w- embryos. The reverse 
primer used to detect both cbt isoforms was 5 -´CCTCGGACATTGTTGGCG-3´; the forward 
primer for the cbt-RB isoform was 5´-TGGGTCAATGCTGGTCAG-3  ´and for the cbt-RA 
isoform was 5 -´GGATACCTTGCTACCTTC-3´. For the Northern blot, total RNA (30 µg 
per lane) from w-, cbtEP(2)2237E1 and cbtEP(2)2237E28 homozygous embryos and arm-
GAL4/UAS-cbt embryos was separated by formaldehyde gel electroforesis and blotted onto 
a positively charged nylon membrane (Roche). cbt and RP49 antisense RNA probes were 
generated as described. Hybridization and washes were performed as described by the 
supplier (Roche). The blots were detected immunochemically with CDP-Star (Roche). 
 
Embryo phenotypic analysis 
Embryos for SEM were prepared as described (Jacinto et al., 2002), except that the vitelline 
membrane was removed using heptane-methanol 1:1. Specimens were imaged on a Hitachi S-
2500 scanning electron microscope. For cuticle analysis, embryos were collected during 24 h 
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and aged an additional 24 h, then they were dechorionated in commercial bleach for 3 
minutes, and the vitelline membrane removed using heptane-methanol 1:1. After several 
washes in methanol, embryos were mounted in Hoyer s´-lactic acid 1:1 and allowed to clear at 
65ºC overnight. Some homozygous mutant embryos showed a bigger head than wild types. 
This led us to name this gene cabut, which means “bigheaded” in the dialect of Valencia. 
These “bigheaded” embryos have a very weak dorsal-open phenotype. 
 
Embryonic lethality assays 
The embryonic lethality rescue of the cbtEP(2)2237E1 homozygous mutant overexpressing UAS-
cbt was performed using several GAL4 lines (X-GAL4, were X can be 69B, da or P0180; all 
on the third chromosome and homozygous viable). For these assays we performed the 
following crosses: cbtEP(2)2237E1/CyO with X-GAL4 homozygous flies and cbtEP(2)2237E1/CyO 
with UAS-cbt/TM3 flies. The non-balanced offspring of both crosses was then crossed 
together, and we measured the percent embryonic lethality in this cross. If there was no 
rescue, we would expect 25% embryonic lethality: 18.25% corresponding to 
cbtEP(2)2237E1/cbtEP(2)2237E1;Y/+ (were Y can be UAS-cbt, X-GAL4 or the wild-type 
chromosome) embryos and 6.25% corresponding to cbtEP(2)2237E1/cbtEP(2)2237E1;X-GAL4/UAS-
cbt embryos. If there is any rescue, the embryonic lethality will be reduced. As all the 
embryos homozygous mutant for cbtEP(2)2237E1 die, we can calculate the absolute embryonic 
lethality rescue as: (25%-observed % embryonic lethality)/6.25% x 100 (Table 1). The 
embryonic lethality rescue of the cbtEP(2)2237E1 homozygous mutant overexpressing UAS-dpp 
was performed similarly, but using only the 69B-GAL4.  
To test for genetic interactions between cbt and hep, we performed the following cross: 
cbtEP(2)2237E1/CyO with 69B-GAL4 homozygous flies. The non-balanced offspring was then 
crossed to UAS-HepAct homozygous flies, and we measured the percent embryonic lethality 
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in such cross. If there was not genetic interaction, we would expect 50% embryonic lethality: 
25% corresponding to 69B-GAL4/UAS-HepAct embryos and 25% corresponding to embryos 
that overexpress HepAct and contain the cbtEP(2)2237E1 allele. If cbt is downstream of hep, the 
embryonic lethality will be reduced. As all the embryos that overexpress HepAct die, we can 
calculate the embryonic lethality due to the genetic interaction as: 100-[(50%-observed % 
embryonic lethality)/25% x 100] (Table 2). 
 
Histology and immunohistochemistry 
Embryos were fixed and stained using standard protocols. Fixation was carried out using 4% 
parafolmaldehyde diluted in PBS and desvitellinization in heptane-methanol 1:1. We used the 
following primary antibodies: rabbit anti-Cno (1/200; Takahashi et al., 1998); rabbit anti-Dlg 
(1/200; Woods et al., 1996); mouse anti-FasIII (1/50; Developmental Studies Hybridoma 
Bank) and rabbit anti-myosin II heavy chain (1/1000; Jordan and Karess, 1997). The 
fluorescent-conjugated secondary antibodies (Calbiochem) were used at a 1/40 dilution. 
Specimens were mounted in Mowiol and examined under a Leica TCS SP2 confocal 
microscope. Several Z sections of each embryo were taken and processed. β-galactosidase 
was detected with a mouse antibody (1/200, Promega). For anti- β-galactosidase stainings, 
biotinylated secondary antibodies were used in combination with the Vectastain Elite ABC 
kit. Anti-β-galactosidase and in situ hydridization double stainings were done as described 
(Manoukian and Kraus, 1992). 
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RESULTS 
 
Molecular characterization of cabut 
cabut (cbt) was identified in a modular misexpression screen of 2200 different EP lines (Rørth 
et al., 1998) looking for genes involved in the establishment of epithelial planar cell polarity, 
as an insertion (EP(2)2237) that caused planar polarity defects in the eye, wing and thorax 
when expressed under the control of sev-GAL4 and ap-GAL4, respectively (Marek Mlodzik 
and N.P., unpublished). To identify the gene overexpressed by EP(2)2237 , we cloned and 
sequenced the adjacent DNA and identified corresponding ESTs in the BDGP database. 
EP(2)2237  is inserted 14 bp upstream of the predicted gene CG4427 in the Gadfly database 
(Fig. 1A). We have named this gene cabut (see Materials and methods), which is located at 
position 21C6 on chromosome arm 2L. Two different mRNA products have been associated 
to CG4427, CG4427-RA and CG4427-RB, although our results indicate that CG4427-RB is 
probably an artifact (see below). CG4427-RA (hereafter called cbt-RA) mRNA encodes a 
protein of 428 amino acids that contains a serine-rich region at the amino terminus, and three 
classical zinc finger domains C2H2 type at the carboxy-terminal region (Fig. 1C), which are 
located in tandem and match the consensus sequence described as CX2-4CX12HX2-6H (Iuchi, 
2001). An alignment of the three Zn fingers found in the Cbt protein is shown in Fig. 1D. 
Database searches identified many proteins with similar domains and from many different 
organisms (data not shown), most of them classified as Sp1-like transcription factors, 
Krüppel-like factors, TGFβ inducible early growth response proteins or BTE-binding 
proteins. In general, proteins with three C2H2 zinc fingers may bind DNA, RNA or proteins 
through the fingers, although most of them are DNA-binding proteins that, together with other 
factors, participate in controlling transcription of target genes (Iuchi, 2001). Thus, the 
probable role of Cbt is to bind to specific regions of DNA and to regulate gene expression. 
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Expression of cbt in embryos and imaginal discs 
The spatial expression pattern of cbt in embryos and imaginal discs was examined by whole-
mount in situ hybridization with a cbt-RA RNA probe. The initial expression of cbt is 
observed at the cellular blastoderm stage in an ubiquitous manner (Fig. 2A). This ubiquitous 
expression persists till stage 8. Then, at stage 9 cabut is mainly expressed in the gut 
primordium and also in the epidermis (data not shown). During stage 11 and onwards, cabut 
is expressed in the yolk cell nuclei and in the lateral epidermis (Figs. 2B-C). cbt expression in 
the yolk cell has been confirmed by using an enhancer trap line in the basigin  (bsg) gene (Fig. 
2C), which is expressed in that tissue (Reed et al., 2004). Moreover, cbt transcripts can also 
be detected in the posterior gut (Fig. 2B). At later stages, when the yolk cell is included in the 
gut, expression of cbt is also present there. In third instar larvae, cbt expression is largely 
ubiquitous in all imaginal discs (data not shown). Similar hybridization experiments 
performed with RNA probes specific for the cbt-RB isoform yielded negative results. To 
confirm this, we performed RT-PCR experiments designed to distinguish between cbt-RA and 
cbt-RB isoforms in different stages of development. We could only detect cbt products when 
using primers specific for the cbt-RA isoform (data not shown). This indicates that the cbt-RB 
variant (indeed represented by only two ESTs in the BDGP, see Material and methods) 
probably corresponds to an artifact generated during cDNA preparation. 
 
Genetics of the cbt locus 
To generate cbt mutations we took advantage of the EP(2)2237 element inserted in the 
upstream region of cbt, which is homozygous viable. Several lethal excisions were obtained 
after mobilization of the EP element, and two of them (cbtEP(2)2237E1 and cbtEP(2)2237E28) were 
used for further analyses. In order to identify the molecular lesions causing the lethality of 
those excisions, we amplified and sequenced the coding region of cbt from embryos 
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homozygous for both alleles, finding in cbtEP(2)2237E28 mutants 30 additional bp in the original 
insertion site of the EP(2)2237  element (Fig. 1B, see Materials and methods). In cbtEP(2)2237E1 
embryos, the cbt coding region was wild-type. Further PCR analyses of genomic regions 
upstream and downstream of the cbt coding region allowed us to identify the molecular lesion 
in cbtEP(2)2237E1 embryos, since we failed to amplify a genomic region between 3.9 and 4,9 kb 
upstream of the cbt transcription start site (Supplementary Fig. 1). To demonstrate whether 
these mutations were affecting cbt expression, we performed in situ hybridization 
experiments. cbt expression was almost lost in cbtEP(2)2237E1 homozygous embryos, although it 
is weakly detected in the gut (Fig. 2D). In cbtEP(2)2237E28 homozygous embryos cbt expression 
was present in the epidermis and gut, but not in the yolk cell (Fig. 2E). These results were 
confirmed by Northern blot analyses using cbt specific probes. While in cbtEP(2)2237E1 embryos 
cbt transcripts are weakly detected, in cbtEP(2)2237E28 embryos the level of expression of the 
gene is almost wild type (Fig, 2F). In control embryos we detect only a 2-kb transcript 
corresponding to the cbt-RA isoform, thus confirming the results obtained by RT-PCR (see 
above). Our results suggest that the cbtEP(2)2237E1 mutation is probably affecting an enhancer 
element necessary for cbt expression, and can be considered a cbt loss-of-function allele. 
However, cbtEP(2)2237E28 appears to be a very weak allele, in which cbt expression is only 
reduced. 
We also wanted to confirm genetically that the cbt genomic region was affected in both 
excision lines. To do that we used the transposition line Tp(2;1)odd1.10, in which the cbt 
genomic region is transposed to the X chromosome (Nusslein-Volhard et al., 1985). We found 
that males heterozygous for any of both cbt alleles, and carrying the deficiency but not the 
transposition, were lethal. All these results are consistent with the notion that the both 
mutations affect the cbt genomic region and disrupts cbt activity.  
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Loss of cbt function is associated with defects in dorsal closure during embryogenesis 
Since cbt is mainly expressed at the embryonic stage, we analyzed the phenotype of cbt 
mutant embryos. First, we determined the timing and cause of lethality associated with the 
cbtEP(2)2237E1 allele. Lethal phase analysis showed that 100% of homozygous cbtEP(2)2237E1 
animals die during embryogenesis, at late embryonic stage. Cuticle preparations of 
cbtEP(2)2237E1 mutant embryos showed that 98.3 % of  them displayed a failure of dorsal 
closure with characteristic dorsal holes in their cuticles. The size of the holes in such embryos 
is variable (Figs. 3B-C), but it covers most of the dorsal region of the cuticle in 91.7% of the 
mutant embryos. The same analyses performed with the cbtEP(2)2237E28 allele indicated that 
only 78% homozygous cbtEP(2)2237E28 animals die during embryogenesis, and only 2.9% of 
them show anterior holes in cuticle preparations (Fig. 3D). This weak phenotype is consistent 
with our previous results regarding cbt expression in such mutants. Therefore we used the 
cbtEP(2)2237E1 allele for further analyses. To better identify the processes leading to the defects 
observed in cbtEP(2)2237E1 mutant embryos, scanning electron microscopy (SEM) was used to 
visualize embryonic morphology. At early stages of development cbt mutant embryos appear 
normal (Figs. 3E-F), but at stage 14 some of them show an abnormal shape of the 
amnioserosa tissue, suggesting that lateral epidermis elongation does not occur properly in 
those embryos (see below, Fig. 3G). By the end of embryonic development we see embryos 
with dorsal holes (data not shown), and others in which internal organs are extruded (Fig. 
3H), due to an improper closure of these embryos.  
To demonstrate that the lethality observed in cbtEP(2)2237E1 mutant embryos is caused by 
loss of cbt activity, we attempted to rescue it by overexpressing cbt with da-GAL4 (an 
ubiquitous driver). Confirming our assumption, we found that ubiquitous cbt overexpression 
results in a 50.2% of rescue (Table 1). Since cbt is expressed in the epidermis and the yolk 
cell during embryogenesis, we wanted to test its requirement in both tissues. Similar lethality 
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rescue experiments of cbtEP(2)2237E1 mutant embryos were performed by overexpressing cbt 
either with 69B-GAL4 (an epidermal driver) or with P0180-GAL4 (a driver specific for the 
yolk cell). Overexpression of cbt in the epidermis results in a 100% of rescue. However, the 
lethality is partially rescued when cbt is overexpressed in the yolk cell (see Table 2) 
suggesting that cbt activity is mainly required in the epidermis for proper embryonic 
development. 
 
Loss of cbt function affects cell shape changes in the epidermis but not in the 
amnioserosa 
During DC, cells in the epidermis and the amnioserosa undergo shape changes and 
movements. Moreover, the DME cells polarize in the plane of the epithelium. To determine 
whether a failure in these events could be the cause of closure defects observed in cbt 
mutants, we stained cbtEP(2)2237E1 mutant embryos for markers that allowed us to analyze cell 
shape and polarity in the dorsal ectoderm. Dlg and FasIII inmunostainings of those embryos 
revealed that the elongation in the D-V axis of DME cells, and more lateral epidermal cells, 
initiates properly but fails shortly afterwards. In consequence, those cells do not elongate to 
the same extent as in wild-type embryos, and round up (Figs. 4A-D). Moreover, we see that 
occasionally the distribution of Dlg and FasIII in the DME cells is not polarized, since it does 
not disappear from the apical part of the cells. Thus elongation and, in some cases, planar 
polarization of the DME cells do not occur properly in cbt mutant embryos. 
In order to check whether amnioserosa morphogenesis was impaired in cbt mutants, we 
stained cbtEP(2)2237E1 mutant embryos with a anti-Canoe (Cno) antibody, which provides a 
clear view of the shape of amnioserosal cells. Cell shape changes in the amnioserosa begin 
with apical constriction of cells at the anterior and posterior ends of this tissue. The middle 
cells in between the two clusters are elongated perpendicular to the A-P axis, but at the end of 
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DC they are both elongated along the A-P axis and apically constricted (Harden et al., 2002). 
Examination of cbtEP(2)2237E1 mutant embryos revealed that morphogenesis of the amnioserosa 
is not affected by loss of cbt function (Figs. 4E-F and data not shown). Only amnioserosa 
attachment defects are occasionally seen in the mutants (Fig. 4F). 
 
Cytoskeleton activity at the leading edge is disturbed in cbt mutant embryos 
Besides to the temporally ordered redistribution of several cell-surface-associated proteins in 
the plane of the epithelium, the actin cytoskeleton reorganizes in the DME cells during DC. 
This is reflected by the accumulation of large quantities of non-muscle myosin and 
filamentous actin at the LE, which occurs in large aggregates or puncta (Kaltschmidt et al., 
2002; Ricos et al., 1999). To determine whether this process occurs normally in cbt mutants, 
we examined the levels of non-muscle myosin in cbtEP(2)2237E1 mutant embryos and compared 
them to wild-type embryos. (Fig. 5). Our results indicate that the aggregates are missing in the 
mutants, which show a feeble and irregular accumulation of myosin at the LE. This suggests 
that cbt is required for the cytoskeletal organization of the DME cells during DC. Defects in 
the accumulation of myosin at the LE during cable assembly have also been observed in 
embryos homozygous for mutations in members of the JNK cascade and in mutants for Wg 
signaling (Kaltschmidt et al., 2002; Ricos et al., 1999). 
 
cbt acts downstream of the JNK cascade 
Genetic analyses have demonstrated that the JNK signal transduction cascade has a very 
important role during DC, regulating its progression and expression of genes at the LE 
(reviewed by Harden, 2002). Our analysis of epidermal and cytoskeletal phenotypes of cbt 
mutant embryos suggested that this gene could be related to the JNK pathway during this 
process. This prompted us to determine the epistatic relationships between cbt and 
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hemipterous (hep), a JNK pathway component (Glise et al., 1995). Expression of a 
constitutively activated form of Hep (HepACT) in the epidermis with the 69B-GAL4 driver 
causes 100% of embryonic lethality (Table 2), due to the overactivation of the JNK pathway. 
We have found that a reduction of the cbt gene dosage in such embryos, using the 
cbtEP(2)2237E1 mutant allele, led to a reduction of the embryonic lethality to 36.4%. The 
direction of the genetic interaction between cbt and hep supports a role for cbt in JNK signal 
transduction, downstream of hep. As further confirmation of these results, we asked whether 
cbt expression could be modified in embryos with different levels of JNK activity. First, we 
analyzed cbt expression in embryos mutant for basket (bsk) or jun, which encode the the Jun 
N-terninal kinase (Riesgo-Escovar et al., 1996; Sluss et al., 1996) and the transcription factor 
Djun (Hou et al., 1997; Kockel et al., 1997), respectively. In both mutants, cbt expression is 
absent in the epidermis and the yolk cell (Figs. 6B-C). Conversely, we found that cbt 
expression can be induced ectopically by overexpression of a constitutively activated form of 
Hep (HepACT) with en-GAL4 (Fig. 6D). Thus, all these findings suggest that cbt functions 
downstream of JNK signaling. 
As previously mentioned, our in situ experiments showed that cbt expression is not only 
lost in the epidermis but also in the yolk cell, in which the JNK cascade has not been reported 
to be active. It is assumed that prior to DC, JNK signaling is downregulated in the 
amnioserosa (Reed et al., 2001) but as DC approaches to completion, it is upregulated in that 
tissue (Reed et al., 2004). Besides, it has been recently published that there are physical 
interactions between the amnioserosa and the underlying yolk cell, which are mediated by 
integrins (Narasimha and Brown, 2004; Reed et al., 2004). These contacts are accomplished 
by cellular extensions that might facilitate a signaling function between both tissues (Reed et 
al., 2004). We therefore asked whether cbt expression could be affected by mutations in the 
myospheroid (mys) gene, which encodes the βPS integrin (MacKrell et al., 1988). Our results 
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show that cbt expression in the yolk cell nuclei is absent in mys1 mutants, in which apposition 
of amnioserosa and yolk cell membranes is compromised (Narasimha and Brown, 2004). 
Conversely, cbt expression in the epidermis is not affected (Fig. 6E-F). Taken together, these 
results suggest that cbt expression in the yolk nuclei depends on JNK signaling and requires 
the physical interaction between the yolk cell and the amnioserosa, supporting the hypothesis 
that a signaling function could exist between both tissues. 
 
cbt regulates dpp expression at the leading edge 
Since our previous results indicate that cbt expression is regulated by the JNK cascade, we 
wanted to know whether mutations in this gene could affect the expression of the two targets 
of JNK signaling during DC, which are dpp and puc. To test this, we first monitored dpp 
expression in wild-type and cbt mutant embryos. The wild-type expression of dpp is dynamic 
through embryogenesis, but in late embryonic stages is evident in two thin stripes (Fig. 7A), a 
dorsal stripe located at the LE, and a ventral stripe (Glise and Noselli, 1997; Riesgo-Escovar 
and Hafen, 1997). We find that dpp expression is abolished in LE epidermal cells in cbt 
mutant embryos, although the stripe located more ventrally is not altered (Fig. 7B). Moreover, 
we tested dpp expression in arm-GAL4/UAS-cbt embryos finding that ectopic cbt activity 
leads to an expansion of the domain of dpp expression at the LE (Figs. 7C-D). Besides, we 
find that overexpression of cbt with an en-GAL4 driver also induces ectopic expression of 
dpp (Fig. 7E). As previously reported, we see in both experiments that only a subpopulation 
of cells is competent to express dpp  (Morel and Martínez-Arias, 2004). These data 
demonstrate that cbt is a positive regulator of dpp expression at the LE in the dorsal 
epidermis. An additional evidence indicating that dpp is downstream of cbt is the finding that 
dpp overexpression with 69B-GAL4 is able to partially rescue the embryonic lethality of the 
cbtEP(2)2237E1 allele (see Table 1). The second JNK target gene activated in LE cells is puc 
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(Glise et al., 1995; Riesgo-Escovar et al., 1996). The expression of puc was measured by 
using a puc-lacZ enhancer trap (Ring and Martínez-Arias, 1993). Our results indicate that puc 
expression is not altered in the mutants (Figs 7F-G), suggesting that cbt functions in the JNK 
pathway, and downstream of jun, to control dpp expression.  
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DISCUSSION 
 
In this report we describe the characterization of cabut, a new Drosophila gene. It encodes a 
zinc finger-containing protein, and is expressed in the lateral epidermis and the yolk cell 
nuclei. Genetic and phenotypic analyses indicate that cbt is required for proper DC. We have 
shown that a reduction in Cbt function affects several key events during DC: shape changes of 
the DME cells, cytoskeleton dynamics and JNK signaling. Based on molecular data and 
genetic interactions, we show that Cbt acts downstream of the JNK cascade in the epidermis 
and regulates dpp  expression in the LE cells. Our results also suggest the existence of a 
signaling function between the amnioserosa and the yolk cell, which would account for the 
JNK-dependent expression of cbt in the yolk cell nuclei. 
 
Role of cabut in dorsal closure 
Our phenotypic analysis of cbt mutants shows that this gene is required during Drosophila 
DC. Embryos homozygous for a cbt loss-of-function allele exhibit abnormal closure, reflected 
by the presence of dorsal-anterior holes. DC is a very complex morphogenetic movement that 
requires the combined effects of different tissues and involves activation of cytoskeletal 
machineries and signaling pathways (Harden, 2002). Thus, DC results from a sequence of 
coordinated events, and defects in any of them lead to a failure of the whole process. Our data 
indicate that cbt mutant embryos show several defects in the DME cells during DC that can be 
responsible of the closure phenotypes observed. First, the morphology of the DME cells is 
abnormal in the mutants, since they do not elongate properly. Second, mutations in cbt affect 
the cytoskeletal machinery in LE cells. During DC, LE cells assemble an actomyosin cable 
that is necessary to maintain a uniform epithelial advance (Martin and Wood, 2002). In cbt 
mutants we observe an aberrant cable assembly, which shows a very feeble accumulation of 
myosin. Third, the polarization of these cells, reflected by the redistribution of cell-surface-
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associated proteins along the D-V plane (like FasIII or Dlg), is sometimes affected in cbt 
mutants. In those cases such proteins are not cleared from the dorsal most edge of the cells as 
occurs in wild type embryos at the onset of closure. By contrast, morphogenesis of the 
amnioserosa appear to occur normally in absence of cbt function. Thus, based on the 
phenotypes seen in cbt mutant embryos, we conclude that cbt is required at different steps in 
DC. In particular, it is necessary for elongation of the DME cells in the dorso-ventral axis and 
for the assembly of the actomyosin cable at the LE. Its involvement during polarization of the 
DME cells is not clear, since the phenotype observed in the mutants is not very strong. 
Similar DC phenotypes have been found in mutants lacking components of the JNK cascade 
(Harden, 2002; Kaltschmidt et al., 2002; Ricos et al., 1999), suggesting that cbt could be 
related to JNK signaling. 
 
cbt functions downstream of the JNK cascade 
Several lines of evidence have confirmed that cbt acts downstream of JNK signaling during 
DC. First, cbt loss of function is able to partially rescue the lethality caused by overexpression 
of an activated form of Hep in the epidermis. This result is in agreement with a role of cbt 
downstream of the JNK module. Second, analyses of cbt expression in embryos mutant for 
JNK cascade components, like bsk or jun, show that this expression is absent in the epidermis 
and the yolk sac, but not in the gut. This indicates that, at least in those tissues, cbt expression 
is dependent on JNK activation, and confirms our previous result. Besides, we were able to 
induce cbt expression in stripes by overexpressing an activated from of Hep with an en-GAL4 
driver Third, analysis of the expression of dpp and puc, two target genes activated in response 
to JNK signaling in the LE cells during DC (Glise and Noselli, 1997; Martín-Blanco et al., 
1998; Riesgo-Escovar and Hafen, 1997; Zeitlinger et al., 1997), in cbt mutant embryos 
reveals that dpp  but not puc expression is lost in the mutants. Moreover, dpp expression can 
 22 
be induced ectopically by overexpression of cbt. Taken together, our results indicate that cbt 
acts downstream of the JNK cascade and the AP-1 transcription factor Jun, regulating dpp 
expression at the LE. Regarding this, we have found putative AP-1 binding sites in the 
genomic region located upstream of the cbt transcription unit (data not shown). It is tempting 
to speculate that cbt expression is directly regulated by Jun through binding to that genomic 
region. Further experiments will be required to confirm this hypothesis. 
Wg signaling is also required for DC. Indeed it regulates cytoskeleton activity at the LE 
and is also required for the polarization of the DME cells (Kaltschmidt et al., 2002; Morel and 
Martínez-Arias, 2004; Ricos et al., 1999). Since we found that polarization of the DME cells 
is not complete in some cbt mutant embryos, this raised the possibility that cbt might be 
related to Wg signaling. To test this, we analyzed cbt expression in arm and dsh mutants. Our 
results show that cbt expression is not affected in the mutants (data not shown), indicating that 
Wg signaling is not required for cbt expression. This will explain that defects during this 
polarization of the DME cells are only occasionally observed in cbt mutant embryos, and 
confirms that the primary role of the JNK cascade is not the polarization of the DME cells. 
 
JNK-dependent expression of cbt in the yolk cell 
An interesting observation is that cbt expression in the yolk cell nuclei is also dependent on 
JNK signaling. Our results show that cbt expression in that tissue is abolished in embryos 
mutant for JNK components, although there is no reported evidence that JNK signaling is 
active in the yolk sac. Then, how could this be achieved? It has been reported that the JNK 
signaling cascade is active in the amnioserosa and the LE of the epidermis at the beginning of 
DC. Later on, it is downregulated in the amnioserosa but not in the LE cells and, after closure, 
it seems to be upregulated again in the amnioserosa to trigger its disintegration and death 
(Reed et al., 2001; 2004). Recent studies have suggested that the yolk cell is also required for 
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DC (Narasimha and Brown, 2004; Reed et al., 2004). Indeed, an intimate contact between the 
amnioserosa and this tissue during DC, which is mediated by integrins, is necessary to prevent 
anoikis of the amnioserosa. One of these studies has shown that there are cellular extensions 
that allow contact between both tissues, which led to the proposal that these projections may 
facilitate a signaling function between them (Reed et al., 2004). Since JNK signaling is active 
in the amnioserosa during DC, we considered the possibility that this signaling function could 
explain the JNK-dependent expression of cbt in the yolk cell. Our results show that cbt 
expression in that tissue is absent in embryos mutant for myospheroid, which encodes the 
Drosophila βPS integrin (MacKrell et al. 1988). In such embryos there are no physical 
interactions between the amnioserosa and the yolk cell and, in consequence, neither 
communication nor signaling function between both tissues can exist. It has been proposed 
that active forms of ecdysone could be transported from the yolk spheres to the amnioserosa 
(Reed et al., 2004). Although our results do not explain how this signaling could occur or 
which molecules could be responsible for it, it is tempting to speculate that cbt activation in 
the yolk cell nuclei requires communication between both tissues and implicates the transport 
of molecules. A more detailed study of the dynamic invaginations seen in the yolk sac 
membrane, the distribution of Cbt or JNK cascade proteins and their transport between both 
tissues are necessary to confirm this hypothesis. 
 
A model of Cbt function in the epidermis 
Although cbt is expressed in the epidermis and the yolk cell nuclei, DC defects observed in 
cbt mutant embryos could be explained considering that Cbt is only required in the epidermis. 
Indeed, we have shown that the embryonic lethality associated to a cbt mutant allele is totally 
rescued by overexpression of cbt with an epidermal driver, but only partially rescued when 
using a driver specific for the yolk cell. Then, the function of this gene in the yolk cell is still 
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unknown. Narashima et al. (2004) and Reed et al. (2004) reported that the close apposition of 
the yolk cell and the amnioserosa is necessary during DC (and germ band retraction). But it 
remains unclear whether the yolk cell plays an active role during DC or it is only a 
mechanistic/signaling support to the morphogenesis or survival of the amnioserosa. Further 
studies will be required to clarify this issue. 
As we have shown, the zinc finger protein Cbt is required downstream of JNK signaling 
to control actomyosin cable assembly at the LE, elongation of the DME cells, but also to 
maintain dpp expression in those cells. Although our results do not address the molecular 
mechanism, we have proposed several models to explain one of these functions, such as dpp 
activation. One possibility is that Cbt directly activates dpp  expression by binding to specific 
enhancers of the gene. In this function Cbt may be acting alone, or it may need putative 
partners that would cooperate or potentiate its function. Alternatively, we can imagine a 
different situation where dpp activation is not direct but mediated by another gene that would 
be activated by Cbt. Moreover, Cbt could also activate the expression of other genes 
necessary for cable assembly or epidermal cell elongation. Several experiments are in 
progress in our laboratory to identify possible Cbt partners and other genes that could be 
related to its function. This will help to unravel the exact mechanism of action that allows 
Cabut to regulate gene expression and to determine the exact role of this gene during DC. 
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FIGURE LEGENDS 
 
Figure 1. Molecular structure of cabut. (A) A schematic of the cabut gene locus showing 
the relative position of the EP(2)2237 element. Coding regions are shown in black, non-
coding regions in white, and the intron is depicted as an open triangle. (B) Relative positions 
of the molecular lesions detected in cbtEP(2)2237E1 and cbtEP(2)2237E28 alleles and 3´ end of the 
cbt downstream gene Arc105 . (C) Hypothetical Cbt protein. White boxes represent Zn 
fingers; squared box indicates a Ser-rich region. (D) Alignment of the three Cbt Zn fingers. 
Cysteines and histidines are in bold. 
 
Figure 2. cabut expression during embryonic development. (A-B, D-E) Whole-mount in 
situ hybridization with a digoxigenin-labeled cbt riboprobe. (A) Wild-type cellular blastoderm 
embryo. (B) Stage 13 wild type embryo showing cbt expression in the yolk nuclei, lateral 
epidermis and posterior gut (arrow). (C) Magnification of the yolk cell region of a stage 13 
bsgB39.1M2 embryo doubled stained with β-galactosidase (orange) and cbt riboprobe (blue), 
note that cbt RNA and β-gal colocalize in the yolk cell nuclei (arrow). (D and E) Stage 14 
cbtEP(2)2237E1 and cbtEP(2)223728 homozygous mutant embryos, respectively. Note that in while in 
cbtEP(2)2237E1 the cbt expression is absent in the yolk and epidermis, it persists in the gut. In 
cbtEP(2)2237E28 the expression is only lost in the yolk cell. A and C are lateral views, B and E 
are dorsal views and D is a dorso-lateral view. (F) Northern blot analysis on total RNA 
extracted from w- (lane 1), cbtEP(2)2237E1/cbtEP(2)2237E1  (lane 2), cbtEP(2)2237E28/cbtEP(2)2237E28  
(lane 3) and arm-GAL4/UAS-cbt (lane 4) embryos. In cbtEP(2)2237E1 embryos cbt expression is 
very reduced, but in cbtEP(2)2237E28 is similar to wild type (compare to lane 1). arm-
GAL4/UAS-cbt RNA is a positive control. Expression of RP49 was used as loading control. 
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Figure 3. Phenotypic analysis of cabut mutant embryos. (A-D) Embryonic cuticle 
preparations visualized by dark-field optics. (A) Wild-type embryo. (B-C) cbtEP(2)2237E1 
homozygous mutant embryos. Numbers in B and C represent the percentages of each 
phenotype seen in the mutant embryos analyzed. (D) cbtEP(2)2237E28 homozygous mutant 
embryo. (E-H) Scanning electron microscopy (SEM) of cbtEP(2)2237E1 homozygous mutant 
embryos. (E) Embryo before dorsal closure (stage 11), (F) during germ-band retraction (stage 
12), (G) during dorsal closure (stage 14) and (H) at post-dorsal closure stage (stage 17). Scale 
bar in E, 150 µm (applicable to F-H). In all cases dorsal is up, except in H that is a dorsal 
view. 
 
Figure 4. Cell shape changes in the lateral epidermis and the amnioserosa in cbt mutant 
embryos. Confocal fluorescent micrographs, assembled from Z-sections, of the boundary 
between the amnioserosa (top) and epidermis midway through DC, except E and F that are 
dorsal views of the amnioserosa. (A, C, E) Wild-type and (B, D, F) cbtEP(2)2237E1 homozygous 
mutant embryos. (A, B) Distribution of FasIII and (C, D) Dlg to reveal the shape and polarity 
of cells in the dorsal ectoderm. As dorsal closure proceeds, cells of the dorsal epidermis are 
elongated in the D-V direction and polarized (A, C). Note that in cbt mutants dorsal epidermal 
cells fail to elongate and Dlg or FasIII are occasionally mislocalized to the LE (arrows in B 
and D). (E, F) Distribution of Cno to outline amnioserosal cells. Note the successful 
constriction of cells at the ends of the amnioserosa of the cbt mutant embryo (arrowheads in 
F). The arrow points to an amnioserosa-epidermis attachment defect. Scale bar in A, 40µm 
(applicable to B); scale bar in C and E, 100µm (applicable to D and F, respectively). 
 
Figure 5. Cytoskeleton activity at the leading edge is disturbed in cbt mutant embryos. 
Anti-non muscle myosin II stainings in (A) wild-type and (B) cbt mutant embryos to visualize 
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the contractile cable at the LE. Note the elevated and punctate distribution of myosin in wild-
type embryos, which accumulates in large aggregates at the LE. cbt mutant embryos show a 
feeble and irregular accumulation of myosin at the LE, and the protein is depleted in patches 
(arrows). Scale bar in A, 100µm (applicable to B). 
 
Figure 6. cabut is downstream of JNK signaling. Distribution of cbt RNAs in stage 13 
embryos (except D: stage 10 embryo). (A) Wild-type embryo. (B) bsk2 (C) jun2, (E-F) mys1 
homozygous embryos. F is a magnification of E. (D) en-GAL4/UAS-HepAct embryo showing 
ectopic cbt expression (arrow points to one example). Note that cbt expression is totally 
absent in jun and bsk mutant embryos, both in the yolk cell and epidermis. However cbt 
expression in the epidermis persists in mys1 embryos (E). In the gut, cbt expression persists in 
all mutant embryos. Dorsal is up, except in A that is a dorsal view. 
 
Figure 7. Mutations in cbt affect dpp but not puc expression. (A-F) Whole-mount in situ 
hybridizations with a digoxigenin-labeled riboprobe for dpp. (A) Wild-type embryo at stage 
13. (B) cbtEP(2)2237E1 homozygous mutant embryo of the same stage. The dpp expression at the 
LE (arrow) depends on JNK signaling, note that this expression is absent from the LE in the 
cbt mutant embryo. (C) Wild-type stage 10 embryo. (E) arm-GAL4/UAS-cbt embryo. (F) en-
GAL4/UAS-cbt embryo. Note that overexpression of cbt, induces ectopical expression of dpp. 
(E-F) puc enhancer trap expression. (F) pucE69/+ embryo, (G) cbtEP(2)2237E1; pucE69/+ embryo. 
Note that puc expression in the LE cells persists in the cbt mutant embryo. 
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SUPPLEMENTARY DATA 
 
Figure S1. PCR analysis of the cbt upstream region. (A) Scheme of the cbt genomic region 
showing the position of PCR fragments (1-5) amplified using overlapping primers (arrows). 
(B) Gel electrophoresis of the PCR fragments. Each PCR analysis was performed using 
genomic DNA extracted from EP(2)2237 flies (fragments 1a, 2a, 3a, 4a and 5a) and from 
cbtEP(2)2237E1 mutant embryos(fragments 1b, 2b, 3b, 4b and 5b); VI indicates the molecular 
weight marker (Roche), –  is the PCR negative control. All PCR reactions were performed 
simultaneously and with the same amounts of genomic DNA: Note that the fragment 5 is 
amplified in EP(2)2237 flies but is weakly amplified in cbtEP(2)2237E1 mutant embryos. Since 
the embryos used for DNA extraction were not dechorionized, marginal amplification is 
detected in the mutants. 
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Table 1. Lethality rescue assays 
 
Genotype Lethal 
embryos/Total 
Lethality rescue 
cbtEP(2)2237E1/cbtEP(2)2237E1;da-GAL4/UAS-cbt 447/2045 50.2% a 
cbtEP(2)2237E1/cbtEP(2)2237E1;69B-GAL4/UAS-cbt 329/1858 100% a 
cbtEP(2)2237E1/cbtEP(2)2237E1;P0180-GAL4/UAS-cbt 398/1873 60% a 
UAS-dpp;cbtEP(2)2237E1/cbtEP(2)2237E1;69B-GAL4/+ 575/2757 66.2% a 
a Embryonic rescue is expressed as a percentage of the expected maximum of 6.25% 
 
Table1
Table 2. Genetic interaction assay between hep and cbt 
 
Genotype Lethal embryos/Total Embryonic lethality 
UAS-HepAct/+;69B-GAL4/+ 1203/1203 100% 
UAS-HepAct/cbtEP(2)2237E1;69B-GAL4/+ 440/1290 36.4% a 
a Embryonic lethality is expressed as a percentage of the expected maximum of 25% 
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